ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,095Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 55

$606K Total Retail Price of All Prescriptions

Rank: 7 out of 55

317 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

26% of this provider’s 317 patients filled at least one prescription for a schedule three drug, compared to an average of 21%.

Risky Drugs to Seniors

2% of this provider’s 8,072 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LEVOTHYROXINE SODIUM 463 414 1 3
HYDROCODONE-ACETAMINOPHEN 345 276 S3 2 1
FUROSEMIDE 285 253 3 5
OMEPRAZOLE 276 225 4 4
AMLODIPINE BESYLATE 225 212 5 9
POTASSIUM CHLORIDE 224 209 6 7
SIMVASTATIN 221 211 7 6
LISINOPRIL 218 193 8 2
HYDROCHLOROTHIAZIDE 174 151 9 15
ATORVASTATIN CALCIUM 160 125 10 19
CELEBREX 135 123 11 55
METOPROLOL TARTRATE 126 105 12 14
METOPROLOL SUCCINATE 125 123 13 18
ENALAPRIL MALEATE 123 106 14 68
NAMENDA 110 110 15 23
DONEPEZIL HCL 108 107 16 24
CLOPIDOGREL 103 88 17 30
SERTRALINE HCL 101 100 18 22
GABAPENTIN 100 84 19 10
DIGOXIN 98 94 20 43
CRESTOR 95 95 21 64
CITALOPRAM HBR 93 78 22 12
PRADAXA 90 85 23 156
NEXIUM 86 85 24 20
TRAMADOL HCL 82 72 25 13
CLONIDINE HCL 79 64 26 38
ALLOPURINOL 78 72 27 31
CARVEDILOL 78 65 27 35
LANTUS 78 67 27 37
RANITIDINE HCL 75 62 30 29
DIOVAN 72 69 31 109
ZOLPIDEM TARTRATE 70 55 32 17
KLOR-CON 10 67 63 33 141
TRAZODONE HCL 64 63 34 39
BUSPIRONE HCL 64 64 34 175
QUETIAPINE FUMARATE 63 53 36 57
PLAVIX 63 55 36 53
MIRTAZAPINE 62 57 38 66
LEVOFLOXACIN 60 54 39 109
SPIRIVA 58 38 40 81
TRIAMTERENE-HCTZ 58 55 40 91
NATEGLINIDE 56 52 42 185
PAROXETINE HCL 54 42 43 60
WARFARIN SODIUM 53 49 44 21
SYNTHROID 53 53 44 139
MELOXICAM 52 46 46 11
RAMIPRIL 51 48 47 196
GLIMEPIRIDE 50 37 48 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.